An interventional study of Video-Based HPV Education and Face-to-Face HPV Education in Human Papillomavirus (HPV) Infection and HPV Vaccination Acceptance/Intention, sponsored by Emel GÜÇLÜ CİHAN. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 24 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by Emel GÜÇLÜ CİHAN · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 19 studies in Papillomavirus Infections with a site in Turkey — 1 open to participants now, 2 under way, none of them phase 3. Papillomavirus Infections · Turkey.
Among the 19 studies in Papillomavirus Infections with a site in Turkey, this one is the 3rd largest by enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2025, is one of 15 with no phase, and was the 12th registered.
581 studies on the registry are indexed under Papillomavirus Infections; 133 are open to participants now.
Browse Papillomavirus Infections studies →1 of the 19 studies in Papillomavirus Infections with a site in Turkey is open now. Recruiting first, the newest first:
Bilecik Seyh Edebali Universitesi · Sites in Turkey
Ages 30–65 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 89 Papillomavirus Infections studies recruiting now, 40 (45%) set no upper age limit and 44 (49%) stop at 75 or younger; 19 take children under 18; 36 take healthy volunteers.
This study: 18 Years to 24 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
19 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 3 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 159 is below the median of 229 across 406 interventional studies indexed under Papillomavirus Infections.
Median enrollment 90 across the 15 interventional studies, 232 across the 4 observational. Of the 16 that completed or were terminated, 1 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 19 has an industry lead sponsor. The 10 most frequent:
Emel GÜÇLÜ CİHAN is the lead sponsor of 2 studies on the registry; 1 is open to participants now.
Emel GÜÇLÜ CİHAN has 1 study filed under Papillomavirus Infections — fewer than ten, so there is no comparison to draw.
1 of the studies in Papillomavirus Infections with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07920666Bilecik Seyh Edebali UniversitesiLived Experiences of Women Diagnosed With HPV Infection | 2026-12 |
Add it to your calendar (.ics) → With an account.
Among the 19 studies in Papillomavirus Infections with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention.
The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years.
The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group.
Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained.
Research Questions
Does HPV education delivered through different methods increase HPV knowledge levels among young women?
Does HPV education increase HPV vaccination intention compared with the control group?
Is face-to-face education more effective than video-based education in increasing vaccination intention?
Are the improvements in knowledge and vaccination intention sustained one month after the education?
This study is a randomized controlled intervention designed to evaluate the effects of different educational methods on HPV and HPV vaccination knowledge level and vaccination intention among young women aged 18-24 living in the Afşin district of Kahramanmaraş, Türkiye. Participants will be randomly assigned into three groups: control group, video-based education group, and face-to-face education group.
At the beginning of the study, a pre-test will be administered to determine participants' baseline HPV and HPV vaccine knowledge and vaccination intention. Educational interventions prepared in accordance with national health guidelines will be delivered to the intervention groups, while no training will be provided to the control group. Immediately after the education sessions, a post-test will be applied to assess short-term effects, and a follow-up assessment one month later will evaluate the persistence of the effect.
Data will be collected at three time points using an introductory information form, the HPV Knowledge Scale, and the HPV Vaccination Attitude and Intention Form. The findings will be used to compare the effectiveness of different educational methods on HPV knowledge level and vaccination intention.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Participants must meet all of the following criteria to be included in the study:
Aged 18-24 years,
Residing in Afşin district, Kahramanmaraş province,
Willing to voluntarily participate in the study,
Literate and able to understand survey questions in Turkish,
Have not previously received the HPV vaccine,
Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test),
Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study.
Exclusion Criteria:
Participants will be excluded if they meet any of the following conditions:
Under 18 or over 24 years of age,
Have received the HPV vaccine or started the vaccine series,
Have been diagnosed with HPV infection,
Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test),
Illiterate or unable to understand the study forms in Turkish,
Withdraw from the study or indicate unwillingness to continue participation,
Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.
Participants in this group will not receive any HPV education during the study period and will complete the same assessments as the intervention groups at all measurement time points.
Participants in this group will receive HPV and HPV vaccination education delivered through a standardized educational video prepared in accordance with national health guidelines.
Behavioral: Video-Based HPV Education
Participants in this group will receive HPV and HPV vaccination education through face-to-face training provided by the researcher using standardized educational materials.
Behavioral: Face-to-Face HPV Education
A structured educational video providing information about HPV infection, transmission, prevention, and HPV vaccination.
A structured face-to-face educational session conducted by the researcher covering HPV infection, transmission, prevention, and HPV vaccination.
Participants will receive HPV and HPV vaccination education through a standardized educational video including information about HPV transmission, related diseases, prevention methods, and the benefits of vaccination.
Participants will receive HPV and HPV vaccination education through a structured face-to-face session conducted by the researcher using standardized educational materials.
HPV Knowledge and Vaccination Intention - Pre-Test
Young women who consent to participate in the study will complete the Participant Information Form and the HPV Knowledge and Vaccination Intention Scale before receiving any education. This stage aims to determine participants' baseline knowledge and intention to vaccinate.
Time frame: Before education
HPV Knowledge and Vaccination Intention - Post-Education Test
Immediately after the intervention, the experimental groups will receive the designated educational methods (video-based education and face-to-face education), and the same scales will be re-administered. This measurement is intended to evaluate the short-term effect of the education. The control group will not receive any education at this stage, only the assessments will be conducted.
Time frame: Immediately after education
HPV Knowledge and Vaccination Intention - 1-Month Follow-Up Test
One month after the educational intervention, all groups will complete the same scales again to assess the persistence of changes in knowledge and vaccination intention. This measurement evaluates the sustained effect of the educational interventions.
Time frame: : 1 month after education
Plan to share: No — Individual participant data will not be shared because the dataset contains sensitive personal information related to participants' health, vaccination intention, and demographic details. To protect participant confidentiality and privacy, access to the data is restricted to the research team.
No publications or documents are linked to this record.
Ran from Dec 2025 to primary completion in Jan 2026, 1 month.
Of 110 non-industry interventional studies with no phase under Papillomavirus Infections, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 48. This study's 1 month is below that.
Counting every sponsor, half of 119 studies reached it within 26 months; a quarter within 10 and three quarters within 48.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Emel GÜÇLÜ CİHAN